Assessing psychological needs in female cancer patients: A tailored model by Miraglia Raineri, A. et al.
Assessing psychological needs in female cancer patients: a 
tailored model
Alessandra Miraglia Raineri1 2, Rosapia Lauro Grotto1 3, Giulia Fioravanti1, Silvia Casale1, 
Francesco Rotella4, Leonardo Fei 5, Alessandro Villanucci6, Gianni Amunni7, Carlo Faravelli1
1Department of Health Sciences, Psychology Unit, University of Florence, Florence, Italy; 2 Department of Neurofarba, Uni-
versity of Florence, Italy; 3 Multidisciplinary Analysis of Relationships in Health Care Laboratory, UNISER, Pistoia, Italy; 4 
Psychiatric Unit, AOU Careggi Hospital, Florence, Italy; 5 Psycho-Oncology Unit - AOU Careggi Hospital, Florence, Italy
6Translational Oncology Unit, AOU Careggi, Florence, Italy; 7 Department of Biomedical, Experimental and Clinical Sciences, 
University of Florence, Direttore Generale Institute for Cancer Research Prevention and Clinical Network, Florence, Italy.
Abstract. Background and aim of the work. Psychosocial needs in cancer patients seem to be underestimated 
and undertreated. !e present research was designed to explore under-considered psychosocial needs (e.g., 
stressful life events, perceived social support, sense of mastery and depressive/anxious symptoms) of a female 
cancer group. !e aim of the study was to test an assessment psycho-oncological model for female cancer 
patients. An assessment model of psychosocial needs and Stressful Life Events was operationalized and tests 
its predictive power. Methods. We used Discriminant Analysis to test predictive power of the model and of 
the single variables included in it. 236 oncological patients (mean age 55.50 ± 13.09) were matched with 
232 healthy control groups in the study. !e following instruments were chosen: the Florence Psychiatric 
Interview, Hospital Anxiety Depression Scale, Multidimensional Scale of Perceived Social Support, Beck 
Depression Inventory I, and Sense of Mastery. Results. !e model satisfied the assumption criteria and was 
significant (Ʌ= .680, X2 = 109.73, p< .001). Conclusions. Stressful events, depression and anxiety were adequate 
markers of the assessment psycho-oncological model proposed for female cancer patients. !e present study 
provides contributions in a clinical perspective: the results support the relevance of considering an assessment 
psychosocial model to use in female oncology for an accurate estimation of the women’s needs. Women af-
fected by female cancer with an history of Stressful Early and Recent life events and high level of anxiety and 
depression could positively benefit from a psychotherapy treatment. (www.actabiomedica.it)
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Background
According to the recent literature, psychosocial 
needs in cancer patients seem to be underestimated 
and undertreated (1-5). Under-considered psychoso-
cial needs can a"ect distress level, patient’s quality of 
life and adherence to treatment (1, 4, 5). Some psy-
chosocial dimensions may contribute to distress inten-
sity related to cancer treatment: lack of social support, 
low sense of mastery, a"ective disorders, other stress-
ors (e.g., concurrent stressful life events and comorbid 
conditions), lack of economic resources, and individual 
characteristics (6-10).  Over the past 30 years, stress-
ful life events have been used as a measure for quan-
tifying stress (11, 12). Several discussions have been 
proposed to explain the mechanism by which social 
support influences the impact of stressful life events 
on adjustment (13-16). Stressful events occurring in 
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Methods
Aims
!e aim of the current study is to test a model for 
assessment procedure of psychoncological factors in 
female oncology. Specifically, the purpose is to deter-
mine the extent to which the theoretical model is con-
sistent with the already consolidated literature on this 
topic (3, 4, 6, 8, 10, 11, 17, 18, 24). 
Research Design and Participants
A case-control study was designed.  !e study 
enrolled 236 women su"ering from female cancer 
(breast cancer, ovarian cancer, endometrial) hospitalized 
or in Day Hospital treatment between January 2009 to 
January 2011. !e sample was selected among women 
admitted to Gynaecological oncology and Breast Unit, 
both a"erent to Careggi University Hospital (Florence, 
Italy). Exclusion criteria were age <18 and >75 years, 
intellectual disability, and not fluent in Italian. 
A control group of 232 healthy women was 
recruited by a convenience sampling (matched for age 
and education to the clinical group). It was selected 
using a case-control method from a pool of 1077 sub-
jects representative of the general population living in 
the same area (the region of Tuscany, central Italy). 
!ese were randomly recruited from the regional lists 
of the Italian National Health System (99.7% of the 
citizens are included in the list of the NHS). 
!e inclusion criteria for controls were being free 
of cancer or other malignant disease and living in the 
same geographical area of the clinical population (the 
region of Tuscany, central Italy). !e mean age of the 
control group was 53.75 (SD = 13.6) years whereas the 
mean age of the clinical group was 55.50 (SD = 13.09) 
years. !e level of education was 10.57(SD = 4.5) years 
for the control group and 10.76(SD = 4.39) for the 
clinical group. 
Measures  
Data collection was implemented considered 
the model of assessment proposed (Figure 1), using 
the presence of social support are assumed to produce 
less distress relative to events occurring in the absence 
of social support (17-19). In physical diseases and 
psychopathology, social support is a relevant and pro-
tective factor that can mediate adaptation in patients 
su"ering from a disease (20-23). 
Despite the fact that previous research has clearly 
demonstrated the association between di"erent stress-
related psychosocial factors and cancer (24), no study 
has implemented an integrated model of psychoso-
cial needs (i.e. Early Life Events, Recent Life Events, 
depressive and anxious symptomatology, perceived 
social support and sense of mastery) in female cancer 
patients (female su"ering from Breast, Endometrial 
and Ovary cancer), a population particularly vulner-
able to psychosocial distress (24, 25).
To fill up this gap, we proposed and implemented 
a psychosocial model for assessment procedure (Fig-
ure 1) inspired by dimensions suggested by literature 
(24- 26), to investigate what psychosocial factors can 
discriminate between an oncological and a control 
group. To our Knowledge do not exist a study focus on 
psychological assessment for female cancer group. !e 
psychological condition of this target was considered 
and discussed in literature (3, 4, 6, 8, 10, 11, 17, 18, 24) 
but to our knowledge do not exists a shared specific 
assessment procedure. !e prevalence of psychological 
disorders in patients with cancer range from 29% to 
47%, including anxiety, depression, adjustment disor-
ders, and other psychiatric diagnoses that would likely 
be induced by medication and general medical condi-
tion (3, 4, 6, 8). Such psychiatric complications and 
psychological challenges impair adjustment capabili-
ties and quality of life of the patient, and also negatively 
a"ect the course of disease and response to treatment 
(8). Stress and related psychosocial factors are associ-
ated with cancer incidence, survival and mortality (10, 
11, 24). Social support was found to enable women 
with cancer to cope with stress and with their disease, 
to psychologically adapt to cancer-related stressors 
and to have enhanced quality of life (17,18). Given 
the importance of the above-mentioned psychosocial 
factor among female cancer patients, it seems relevant 
to systematically explore them by developing a specific 
assessment method.
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semi-structured interviews and written tools. A quan-
titative approach was used, because the data extract 
from interviews was the presence or absence of trau-
matic events. !e qualitative data was therefore treated 
only with a quantitative way.  !e instruments were 
filled out in hospital for clinical group and at partici-
pants’ home for control group. Socio-demographic 
variables and a medical history, including oncological 
diagnosis, age of onset, stage of cancer, current and 
past treatments (e.g., chemotherapy, radiotherapy and 
surgical operation) were also collected. 
Stressful Events
!e Early Life Events and Recent Life Events 
were assessed by means of the Florence Psychiatric 
Interview (FPI), a validated semi-structured interview 
(27).  In particular, respondents were asked
whether they had experienced the following types 
of adversity before the age of 15 (e.g, early life events): 
death of, or separation from, mother; death of, or sepa-
ration from, father; loss and severe illness of any other 
cohabiting relative and severe illness in the subject’s 
childhood su#cient to interfere with the development 
of normal social relationships. Personal accounts were 
recorded extensively, including the contexts, circum-
stances, and timing of any specific adversity. Stressful 
events of the year before the onset of the illness (the 
year before the interview in the case of control sub-
jects) (i.e., recent life events), as well as the circum-
stances and the context in which they occurred were 
also explored by means of the interview. !is proce-
dure, which has been used in the past (e.g., 9, 10) has 
proven reliable. 
!e early and recent live events was then trans-
formed in in two continuous variables. !e first was 
Figure 1. Psychoncological assessment model tested on female cancer group
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a cumulative effect of the Stressful Early Life Events (in 
which we included death of, or separation from mother; 
death of, or separation from, father; loss and severe ill-
ness of any other cohabiting relative) and the second 
was a cumulative effect of Stressful Recent Life Events (in 
which we included: family conflicts, bereavement, loss 
of job/financial problems, health problems, and sexual 
and/or physical abuse). 
Anxiety, Depression, Social Support and Sense of Mastery
Sense of mastery, anxiety and depressive symp-
toms, and social support were assessed using the Italian 
versions of the Sense of Mastery Scale [SOM] (28), 
of the Hospital Anxiety Depression Scale [HADS] 
(29), of the Beck Depression Inventory [BDI] (30) 
and of the Multidimensional Scale of Perceived Social 
Support [MSPSS] (31).!e Italian version (32) of 
the Sense of Mastery Scale (28) assesses the global 
belief in one’s ability to control things and to miti-
gate adverse aversive events (28). !e scale contains 7 
items (e.g., “What happens to me in the future mostly 
depends on me”) which are rated on a 7-point Likert 
scale (from 1 = “Strongly agree” to 7 =”Strongly disa-
gree”. !e total scores range from 7 to 49 with higher 
scores indicate a higher level of self-mastery (32). 
!e Hospital Anxiety Depression Scale [HADS] 
(29) is a 14-item self-report questionnaire on a 4-point 
Likert scale. !e questionnaire includes depression 
and anxiety subscales (7 items for each). !e total 
score ranges from 0 to 42 for all the 14 items, and each 
subscale (depression and anxiety) is scored from 0 to 
21. !e HADS is a useful self-report measure of the 
severity of anxiety and depressive symptoms in pri-
mary care patients and in the general population (33). 
!e HADS has shown good psychometric properties 
as a measure to assess depressive and anxiety symptoms 
in Italian samples (34). !e Multidimensional Scale of 
Perceived Social Support (MSPSS) measures patients’ 
s perceived social support. !e MSPSS assesses per-
ceptions of three dimensions: social support adequacy 
from family, friends, and significant others. !e three 
scales are composed is by four items each.  !is 12–
item scale uses a 7–point Likert type response format 
(1= very strongly disagree; 7= very strongly agree). A 
higher score indicates better perceived social support 
(31). !e Italian version of the MSPSS has shown 
good psychometric properties (35). !e Beck Depres-
sion Inventory II [BDI] (30) quantitatively assesses 
the depressive symptoms perceived by the patient. It 
consists of 21 sentence groups and was independently 
completed by the patient. Each item is rated on a four-
point Likert-type scale ranging from 0 to 3; its total 
score ranges from 0 to 63, with higher scores indi-
cating more severe depressive symptoms. It explores 
the a"ective, cognitive, motivational, vegetative, and 
psychomotor components of depression. Each item 
comprises a list of four statements arranged by the 
increasing severity of a symptom of depression: the 
higher the score, the higher the severity of depressive 
symptoms. Excellent psychometric properties of the 
BDI-II on Italian individuals were found (36).
Data Analysis  
!e interviews were transcript and examined by 
qualified independent investigators, not involved in 
the interviews and blind to the participants’ group sta-
tus. !ey rated whether each descriptive account had 
to be considered a stressful event. 
!e descriptive Statistics of the Psychosocial Var-
iables were compared by One way ANOVA. 
!e data file was inspected for missing data and 
normality of the distribution. !ere were no missing 
data and the respect of Multivariate Normality was 
checked by Mahalanobis distance.  To test the theo-
retical model, a discriminant function (DA), was used. 
Discriminant Analysis (37) is useful when a set 
of independent continuous variables are expected to 
predict an outcome that is expressed by a categorical 
dependent variable; here we are interested in explor-
ing a Discriminant Model in which the outcome vari-
able is the Group (Female Cancer Group vs Control 
Group) while a set of psychosocial and clinical vari-
ables are considered as predictors. Discriminant Anal-
ysis provides an estimate of the classification power of 
the overall set of predictors together with estimate of 
the relative contribution (weight) of each variable to 
the variation of the outcome. 
A linear combination of the predictor variables 
that provide the best discrimination between the 
groups was tested. Discriminant analysis is appropriate 
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when wishing to predict in which group (in this paper, 
those who belongs to clinical or healthy group) par-
ticipants will be collocated. Our model of markers 
tested by DA included the Cumulative E"ect of Early 
Life Events, cumulative e"ect of Recent Life Events, 
Anxiety scale (HADS), Depression scale (HADS), 
Beck Depression Inventory (BDI), Friends Social 
Perceived Support, Family Social Perceived Support, 
Others Social Perceived Support (MSPSS), and Sense 
of Mastery (SOM). Data were analysed using SPSS 
for Windows 22.0 (SPSS Inc., 2013).
Ethical considerations
!e study was approved by the local Florence 
Ethics Committee (acceptance   protocol   number   
2010/0008185 Ref.  19/10 and 2011/0027621 
Ref.  70/11.) and was conducted in accordance with 
introduced and authorized amendments as well as with 
the ethical principles of the Declaration of Helsinki 
(http://www.wma.net/e/policy/b3.htm). !e partici-
pants were informed by the investigator on the pur-
poses and objectives of the research and signed specific 
informed consent to the study and to the processing 
of personal data. An information note was attached to 
the consent, which clarified the voluntary participation 
in the research and the possibility of withdrawing from 
it at any time. !e information also specified that the 
interview and that the data collected would be ana-
lyzed and disclosed in a strictly anonymous form.
Results 
!e descriptive and comparison between the 
female oncological group and the control group (One 
Way Anova) for psychosocial variables was showed in 
Table 1.
!e mean score of stressful events (Early Life 
Events m= 1.14 and Recent Life Events m= 0.50), 
a"ective symptoms when assessed by HADS (anxiety 
m= 8.17 and depression m=7.60), and BDI m= 6.58 
was higher in the clinical group, while sense of mas-
tery m= 31.82 and Perceived Family Social Support 
m=6.42 were lower than control group. All comparison 
above mentioned were statistically significant (p <.01).
 A discriminant analysis was conducted to assess 
whether the nine predictors could allow to distin-
guish between the subject who belonged to the clinical 
Table 1. Descriptive Statistics of the Psychosocial Variables (One way ANOVA).
Oncological group n= 236 Control group n= 232
F pMean Std. deviation Std.Error Mean Std. deviation Std.Error
Cumulative e"ect 
early life events
1.14  1.08 .07 .60 .85 .07 63.26 <.01
Cumulative e"ect 
recent life events
.50 .69 .04 .27 .5 .03 22.09 <.01
Anxiety scale HADS 8.17 3.64 .27 8.09 3.56 .32 8.31 <.01
Depression scale 
HADS
7.60 3.23 .24 6.51 2.88 .26 49.8 <.01
Beck Depression 
Inventory BDI
6.58 6.76 .44 3.81 7.16 .57 38.30 <.01
Friends social 
perceived support
6.11 1.47 .13 5.86 1.69 .16 2.84 <.01
Family social 
perceived support
6.42 1.21 .11 6.47 1.04  .10 5.47 <.01
Others social 
perceived support
6.58 .99 .09 6.55 .96 .09 3.51 <.01
Sense Of Mastery 31.82 8.11 .53 33.76 7.8 .63 19.7 <.01
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group and those who did not. —the predictors were: 
Cumulative effect Early Life Events, Cumulative effect 
Recent Life Events, Anxiety Scale HADS, Depression 
Scale HADS, Beck Depression Inventory BDI, Friends 
Social Perceived Support, Family Social Perceived Sup-
port, Others Social Perceived Support, Sense of Mastery. 
Wilks’ lambda was significant: Ʌ = .680, X2 = 109.73, 
p < .001, and this indicates that the model including 
these nine variables was able to significantly discrimi-
nate between the two groups. 
Figure 2 shows the standardized function coef-
ficients, which suggest that Depression scale HADS, 
Anxiety scale HADS, the Cumulative E"ect of Recent 
Life Events and the Cumulative E"ect of Early Life 
Events (respectively 0.64, 0.54, 0.53, 0.52) contribute 
the most to distinguish between those who belonged 
to clinical group from those who did not, using these 
predictors. !e Standardized Function Coe#cients 
of those variables of the model respect the cut-o" of 
.30. So, scores obtained by variables above considered 
qualify their as valid marker of the model.
!e classification results show that the model cor-
rectly predicts 69.4 % of those who belonged to the 
clinical group (Figure 3). 
Table 2 presents the correlations between the 
study variables and discriminant function. Stressful 
Early Life Events, Stressful Recent life events, Anxiety 
and Depression scale assessed by HADS contributed 
strongly to the discriminant function because their 
r-value exceeds the cut-o" of .30. In fact, their value 
was respectively 0.41, 0.50, 0.33, 0.59. !ose scores 
allow us to consider those variables as adequate mark-
ers of the model tested.
Discussion and Conclusion
Although the present research is not an epide-
miologic study of psychosocial factors in oncology, 
Figure 2. Standardized function coe#cients of the model 
Note. Standardized Discriminant Coe#cients of the final discriminant function that separates out the Female cancer group (n = 
236) from the Control group (n= 232). Standardized Discriminant Coe#cients are the equivalent of beta weights in regression. Good 
predictors tend to have large values of the Standardized Discriminant Coe#cients. In particular valid predictors (named Adequate 
Variables) are variables showing a Standardized Discriminant Coe#cient higher than |.30|. In the present model Adequate Variables 
are: Cumulative E"ect of Recent Life Events, Anxiety scale HADS, Depression Scale HADS, and Cumulative E"ect of Early Life 
Events (here Grey Columns represent the Standardized Discriminant Coe#cients of the Adequate Variables in the model).
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Table 2. Correlations between variables and discriminant func-
tion product by the model comparing a female cancer group 
n= 236 with a control group n= 232.
Dimension assessed Correlation score
Sense of mastery .149
Anxiety scale HADS .331
Depression scale HADS .590
Beck Depression Inventory BDI -.102
Friends social perceived Support .088
Family social perceived Support -.028
Others social perceived Support .071
Cumulative e"ect recent life events .413
Cumulative e"ect early life events .502
Note. Person’s Correlations between the Discriminant Model’s 
Variables and the Standardized Canonical Discriminant Func-
tion (structure matrix). In general, 0.30 is considered to be the 
cut-o" between relevant and less relevant variables.
Figure 3. Classification of those who belonged to the clinical group in model 
Note. !e validity of Discriminant Analysis is tested by contrasting the power to discriminate provided by the Discriminant Model 
with a chance classification: reclassification of the Female Cancer Group (n= 236) and of the Control Group (n= 232) obtained with 
the Discriminant Model. On the left we have reported the “improvement over chance criterion” (IOCC), showing that more that 80% 
of the Female Cancer patients are correctly reclassified by the Discriminant Function (gray bar, left). On the right re-classification 
is obtained with the cross-validation procedure. It is described as a ‘jack-knife’ classification, in that it successively classifies all cases 
but one to develop a discriminant function and then categorizes the case that was left out. !is process is repeated with each case left 
out in turn. !is cross validation produces a more reliable function. Here the di"erence between the results obtained with the two 
methods is minimal, as more than 79% of the Female Cancer patients are correctly reclassified with cross-validation (gray bar, left). 
Both procedures detect a valid discriminative power for the Model
some of the data are useful in terms of understanding 
discriminant factors in female cancer. In accordance 
with previous findings (24), almost all the oncologi-
cal participants in the present study reported more 
psychosocial needs and stressful events (1, 2, 3, 4, 5, 6, 
10, 11, 17, 18, 38) than healthy participants.
Previous empirical findings have shown that 
stressful life events and psychosocial problems (e.g., 
depression, anxiety, and low social support), predis-
pose oncological patients to psychological distress and 
negative outcomes (6, 7, 8, 9, 10, 38).   In the pre-
sent study, the discriminant analysis was performed to 
verify the hypothesis that the variables in the model 
can be consider an adequate marker for a discriminant 
function; thus, the plausibility of the postulated dis-
crimination among groups was tested. !e model was 
able to correctly allocate around 69.4 % of the sub-
jects to the groups. Markers that are more adequate 
were especially those represented by stressful events 
and depressive-anxious symptomatology. !is result 
is in line with the findings from previous studies that 
underline high level of psychological distress in clinical 
sample (6, 7, 8, 9, 10, 39).  
Hence, these results indicate that several com-
ponents, such as adverse life events and psychosocial 
variables, can explain the psychological condition of 
oncological patients at incidence time. Even if the 
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clinical group obtained significant lower scores relative 
to the control group, the results seem to suggest that 
this dimension might be less important in discriminat-
ing between oncological patients and healthy controls 
relative to the other variables assessed by the current 
study.  !ere are some possible explanations for this 
result. 
First, a suppression e"ect might explain this find-
ing as cancer patients’ perception of social support and 
depressive symptoms are strongly inter-related (40). 
Previous studies (41) suggested that the most impor-
tant source of support for cancer patients is the fam-
ily. However, caring for a family member with cancer 
poses significant challenges, with considerable poten-
tial psychosocial consequences for the caregiver, espe-
cially in advanced cancer. On the one hand, this might 
explain the lower scores obtained by cancer patients 
on the measure used to assess social support. On the 
other hand, future studies should focus their attention 
on di"erent sources of support to further clarify the 
association between patients’ s perception of social 
support and depressive symptoms. 
Moreover, whereas previous studies suggest that 
social support from significant others work as a bu"er 
against reaction to stressful events, less studied is the 
potential e"ect of these events on the perception of 
social support itself. It is not possible to rule out the 
possibility that stressful live events have a negative 
impact on the perception of support itself. 
Some limitations of the present study must be 
acknowledged. !e retrospective and cross-sectional 
design of the study obviously introduces the possibility 
of a recall bias caused by cancer diagnosis or memory 
distortion, as patients re-evaluate their lives based on 
their health state and might selectively recall their 
experience before the diagnosis.
For these reasons, only objectively verifiable early 
events were assessed as loss and separation. 
A larger sample and a more detailed investigation 
are therefore necessary to confirm the psychological 
discriminant factors on female cancer and to evaluate 
other factors that may modulate the response to trau-
matic childhood events (e.g., temperament, attach-
ment, and parental style).
Our results are congruent with the clinical obser-
vations of several studies (6, 7, 8, 9, 10, 46), confirming 
the need to consider specific psychosocial needs among 
female cancer patients. 
Identifying patients at particularly high risk for 
psychological adjustment di#culties represents an 
important step toward designing interventions tai-
lored for the di#culties and circumstances of di"erent 
groups (47, 3, 1, 5, 26). 
!erefore, our results point out the importance 
of an accurate assessment procedure of psychosocial 
factors in oncology. Specifically, they suggest the con-
sideration on assessment procedure of four dimen-
sions: stressful events (Cumulative Early life events, 
Cumulative Recent Events Trigger Events), Anxiety 
and Depression assessed by HADS (29). Our find-
ings point out also the relevance to manage the above-
cited dimensions with proper interventions. Women 
a"ected by female cancer with an history of Stressful 
Early and Recent life events and high level of anxiety 
and depression could positively benefit from a psycho-
therapy treatment.
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